Abbott (ABT), Reckitt Unit Defeat Infant-formula Sickness Claims - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures drop over 1% as AI worries resurface, oil climbs
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Join SI Premium – FREE
Abbott (NYSE: ABT), Reckitt Unit Defeat Infant-formula Sickness Claims - Bloomberg
- Abbott, Reckitt Trial Victory Is First In Infant-formula Cases
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Labs (ABT) PT Lowered to $125 at BTIG
- Venu hires two senior talent executives to expand booking team
- WEL Companies adopts Descartes and CARRIER1 freight tech
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, LitigationRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
